SEC-sourced researchBeta
BCPC
BALCHEM CORP
Company comparison ↗
Data passport
- CIK
- 0000009326
- Exchange
- Nasdaq
- Business activity
- Chemicals & Allied Products · SIC 2800
- Financial inputs
- 6/6
- Filing date
- Sep 24, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 922,439,000.0000 | Feb 20, 2026 |
| December 2024 | 953,684,000.0000 | Feb 20, 2026 |
| December 2025 | 1,037,161,000.0000 | Feb 20, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,037,161,000.0000 | 154,845,000.0000 | 216,556,000.0000 | 1,686,252,000.0000 | 428,839,000.0000 | Feb 20, 2026 |
| December 2024 | 953,684,000.0000 | 128,475,000.0000 | 181,999,000.0000 | 1,575,371,000.0000 | 425,458,000.0000 | Feb 20, 2026 |
| December 2023 | 922,439,000.0000 | 108,543,000.0000 | 183,761,000.0000 | — | — | Feb 20, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
81/100
Profitability80
Growth59
Balance sheet75
Cash generation92
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.04B | Jan 1, 2025 – Dec 31, 2025 | Feb 20, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $953.68M | Jan 1, 2024 – Dec 31, 2024 | Feb 20, 2026 | 10-K |
| Net incomeNetIncomeLoss | $154.85M | Jan 1, 2025 – Dec 31, 2025 | Feb 20, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $216.56M | Jan 1, 2025 – Dec 31, 2025 | Feb 20, 2026 | 10-K |
| Total assetsAssets | $1.69B | Dec 31, 2025 | Feb 20, 2026 | 10-K |
| Total liabilitiesLiabilities | $428.84M | Dec 31, 2025 | Feb 20, 2026 | 10-K |
New filings
- 3BCPC · BALCHEM CORPSep 24, 2026 · Other
- 10-QBCPC · BALCHEM CORPJul 31, 2026 · Periodic
- 8-KBCPC · BALCHEM CORPJul 31, 2026 · Current event
- 8-KBCPC · BALCHEM CORPJul 27, 2026 · Current event
- 8-KBCPC · BALCHEM CORPJun 22, 2026 · Current event
- 11-KBCPC · BALCHEM CORPJun 18, 2026 · Other
- 10-QBCPC · BALCHEM CORPApr 30, 2026 · Periodic
- 8-KBCPC · BALCHEM CORPApr 30, 2026 · Current event
- SCHEDULE 13GBCPC · BALCHEM CORPApr 29, 2026 · Other
- SCHEDULE 13GBCPC · BALCHEM CORPApr 28, 2026 · Other
- DEFA14ABCPC · BALCHEM CORPApr 27, 2026 · Other
- DEF 14ABCPC · BALCHEM CORPApr 27, 2026 · Other
- 3BCPC · BALCHEM CORPApr 7, 2026 · Other
- SCHEDULE 13G/ABCPC · BALCHEM CORPMar 26, 2026 · Other
- 10-KBCPC · BALCHEM CORPFeb 20, 2026 · Annual
- 8-KBCPC · BALCHEM CORPFeb 20, 2026 · Current event
- 8-KBCPC · BALCHEM CORPFeb 19, 2026 · Current event
- 4BCPC · BALCHEM CORPFeb 13, 2026 · Other
- 4BCPC · BALCHEM CORPFeb 13, 2026 · Other
- 4BCPC · BALCHEM CORPFeb 13, 2026 · Other